World Sleep Society Issues Guidelines for Wearable Sleep Trackers to Improve Consumer and Clinical Use

Millions of individuals worldwide using wearable sleep devices stand to benefit from the newly released guidelines by the World Sleep Society, aimed at optimizing the use of consumer health trackers (CHTs) for sleep monitoring. This collaborative effort involved leading sleep experts from the United States, Australia, Europe, and Singapore, incorporating feedback from industry stakeholders, clinicians, and previous research.
Published in the journal Sleep Medicine, these recommendations offer practical guidance for consumers, healthcare professionals, researchers, and device manufacturers to harness the full potential of wearable CHTs through evidence-based practices. Once primarily employed for fitness purposes, CHTs are increasingly used to track sleep timing, regularity, and duration. They act as continuous sleep diaries, providing users with long-term insights into their sleep habits, which can positively impact mood, cardiovascular health, brain function, and immunity.
Despite their advantages, the accuracy of CHTs varies significantly across devices, influenced by sensor quality, device algorithms, and lack of standardization. These issues raise concerns among clinicians, prompting recommendations to improve reliability and clinical relevance.
Professor Michael Chee, Director at NUS Yong Loo Lin School of Medicine, emphasized the importance of aligning manufacturers with common standards, fostering collaboration between clinicians and industry to enhance sleep measurement tools. Consumers are advised to select devices that match their specific needs, focusing on fundamental sleep parameters like sleep timing and regularity rather than obsessing over detailed sleep stage data, which may lack accuracy.
Regular tracking encourages users to experiment with pre-sleep routines, discover sleep habits that work best for them, and personalize sleep strategies beyond general guidelines. Moreover, long-term data collection can reveal how cultural, occupational, and environmental factors influence sleep, while advancements in artificial intelligence enable more tailored sleep recommendations.
However, the guidelines acknowledge that CHTs are not designed for clinical diagnosis but emphasize that stronger partnerships between clinicians and manufacturers are crucial as these devices evolve. When guided appropriately, wearable sleep trackers can empower users to make meaningful health choices and improve sleep quality.
These recommendations will be a key topic at the upcoming 18th World Sleep Congress in Singapore, scheduled for September 5–10, 2025.
Source: https://medicalxpress.com/news/2025-04-wearable-trackers-aim-empower-consumers.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
GLP-1 Medications May Offer Superior Protection Against Dementia Compared to Metformin
Emerging research suggests that GLP-1 receptor agonists may offer enhanced neuroprotective effects over metformin, reducing the risk of dementia in individuals with type 2 diabetes. Discover the latest findings and potential implications for future treatment strategies.
Cambodia Records Fifth Bird Flu Fatality in 2025
Cambodia reports its fifth bird flu-related death of 2025, involving a 52-year-old man infected with H5N1. The cases highlight ongoing risks of avian influenza in the region and the importance ofAlert measures.
New Research Identifies PTP1B as a Key Target to Protect the Heart in Obesity and High-Fat Diet Conditions
Research from MMRI identifies PTP1B enzyme as a key driver in obesity-related heart dysfunction, opening new avenues for targeted therapy to protect cardiac health.